November 9-11, 2020 | VIRTUAL EVENT
There have been many COVID driven impacts on customer engagement and marketing processes, tools and tactics. However, even with the advancement of digital marketing and commercial transformation, in-person engagement still remains the cornerstone of the pharma marketing business.
While we should celebrate the small wins and pivots that have been made as a result of COVID forced change, it is vital to understand which of these changes are transitory and which are true, long lasting transformations and innovation to be built on, and embedded in future processes and planning.
These are just a fraction of the issues currently creating bottlenecks that require proactive future planning and careful roadmap development.
Join our expert speaker faculty, the Thought Leadership Council and many of your industry peers to develop this roadmap together as a true community:
- What will be our indicators and measurements of value moving forward?
- What are the content consumption habits/behaviors of HCPs now?
- How can I de-risk from supply chain to product development to commercial activity?
- How can I diversify our clinical trial recruitment and innovation?
- Does reimbursement need to be integrated with innovation?
- How can I effectively virtualize customer engagement, branding and product launches?
- What is the right promotional mix, even if/when sales force can return?
- To what extent are the different stakeholder activities changing/overlapping as business needs evolve?
These are just a fraction of the issues currently creating bottlenecks that require proactive future planning and careful roadmap development.
Join our expert speaker faculty, the Thought Leadership Council and many of your industry peers to develop this roadmap together as a true community:
Speaker Highlights
Carmine Attanasio
Associate Director, Digital Product Marketing, US Hematology - BRISTOL MYERS SQUIBB
John Lineen
Director, Digital Engagement Lead (CV/IM), Worldwide Engagement Planning and Content Capabilities - BRISTOL MYERS SQUIBB
Jessica Pfennig
Enterprise Digital Leader, Compliance Business Partner, Commercial Operations NA and Oncology Business Unit - ASTRAZENECA
Stephen Ranjan
Vice President, Franchise Lead Professional and Non-Insulin Therapy Solutions, Strategy and Customer Solutions - ROCHE DIABETES CARE
Jamie Rosati
Executive Director, Global Human Health, Digital Strategy and Enterprise Social Media Group - MERCK
Bharat Tewarie
Member of the Board of Directors, ALVEO TECHNOLOGIES | Former Chief Marketing Officer, UCB PHARMACEUTICALS
Alison Woo
Head of Content and Editorial, Scientific Communications and Innovation - GLAXOSMITHKLINE
Robert Allen
Lead, Digital Operations and Global Public Affairs - BRISTOL MYERS SQUIBB
Ryan Alovis
CEO - PULSE HEALTH
Carmine Attanasio
Associate Director, Digital Product Marketing, US Hematology - BRISTOL MYERS SQUIBB
Fred Bennett
Former Head Patient Strategy and Engagement - INTERCEPT PHARMACEUTICALS
Asheeh Chhabra
NA Commercial IT Head – Digital, Data and Analytics - GLAXOSMITHKLINE
Sam Cannizzaro
Executive Creative Director - SYNEOS HEALTH
Wendy Blackburn
Executive Vice President of Marketing and Communications - INTOUCH GROUP
David Dejonghe
Head of Portfolio Strategy - LIFESCAN
Jim Delash
Multichannel Marketing Director - GLAXOSMITHKLINE
Zoe Dunn
Principal - HALE ADVISORS
Daphne Early
Director - VIIV HEALTHCARE
Jessica Every
Digital Innovation Strategy Lead - EVOLUTION ROAD, LLC
Lisa Flaiz
Director MCM, Worldwide Digital Hub Lead for Consumer Marketing - BRISTOL MYERS SQUIBB
Dan Gandor
Director, US Customer Experience, Oncology and Virology - ABBVIE
Rich Gorman
Senior Vice President, Commercial Solutions, Syneos Health - SYNEOS HEALTH
Shwen Gwee
Vice President and Head of Global Digital Strategy - BRISTOL MYERS SQUIBB
Kevin Hsieh
Service Lead, Web and Mobile - GENENTECH
Kate Innelli
Director, Digital Health and Innovation - AMGEN
Hans Kaspersetz
CEO - ARTERIC
Morris Kimble
Brand Manager, HCP Marketing – Digital - ELI LILLY
John Lineen
Director, Digital Engagement Lead (CV/IM), Worldwide Engagement Planning and Content Capabilities - BRISTOL MYERS SQUIBB
Paul Murasko
Senior Director, Digital Interaction - IPSEN PHARMACEUTICALS
János Penzes
International eMarketing Manager, Digital Center of Excellence Lead - GEDEON RICHTER
Jessica Pfennig
Enterprise Digital Leader, Compliance Business Partner, Commercial Operations NA and Oncology Business Unit - ASTRAZENECA
Amanda Phraner
Director, Public Relations & Social Media - HORIZON THERAPEUTICS
Stephen Ranjan
Vice President, Franchise Lead Professional and Non-Insulin Therapy Solutions, Strategy and Customer Solutions - ROCHE DIABETES CARE
Jamie Rosati
Executive Director, Global Human Health, Digital Strategy and Enterprise Social Media Group - MERCK
Michael Rowbotham
Digital Strategy Lead for Xeljanz Franchise, Director MCM - PFIZER
Igor Rudychev
Head of Commercial Analytics - NOVARTIS
Paul Savidge
US General Counsel - SPARK THERAPEUTICS
Melissa Saw
Director – Marketing Procurement - BAYER
Bharat Tewarie
Member of the Board of Directors, ALVEO TECHNOLOGIES | Former Chief Marketing Officer, UCB PHARMACEUTICALS
Alex Vandevere
Associate Director, US Marketing, ORENCIA/Immunology - BRISTOL MYERS SQUIBB
John Vieira
Head of Commercialization - US, SOL-GEL TECHNOLOGIES
Alison Woo
Head of Content and Editorial, Scientific Communications and Innovation - GLAXOSMITHKLINE
Francesca Wuttke
Chief Digital Officer - ALMIRALL
Registration Price
Complimentary Re:Imagine Pharma VIP Pass
(Must be employed by a Pharmaceutical, Biotech, or Medical Device Company to Qualify)
- Interested in meeting with pre-approved Solution Providers offering cutting-edge solutions that can help you Re:Imagine your marketing plans? Apply for a complimentary Re:Imagine Pharma VIP pass in order to receive an all-access pass to the event at no cost.
Registration
Pharma/Biotech/Medical Device Companies
- Standard $795
Registration
Suppliers/Vendors/Agencies
- Standard $995
Group Discounts Available! Contact Gabby Robles at gabby@momentumevents.com
Click here to view the cancellation/refund/transfer policy.
REASONS TO ATTEND
○ Amplify digital at a critical time – identifying what the triggers for ‘must do’ changes, and assessing if these are these connected to true long lasting digital transformation
○ Examining COVID forced acceptance of Omnichannel marketing importance: where do CX and MCM groups need to channel their energy and what elements to prioritize to deliver a consistent experience of your brand
○ Analyze content consumption habits and behaviors of HCPs to develop your content and engagement strategy
○ Scaling video content – keeping the authenticity; examples of good stories that make for great content and pull the story forward to capture emotion
○ Quantify the right multichannel mix to select the right channel for the corresponding campaign
○ Optimize your patient journey and adherence as a marketing aid – how ‘how to’ and ‘why’ build as patients continue to increase levels of expectation on access and reach
○ Build a successful performance measurement framework to better interpret your data and understand your goals within analytics
○ Minimize data noise and digital health errors through smart use of data analytics and combining data sources
○ Reimbursement: relocating reimbursement as part of the innovation process – understand the value proposition of tech and quantify the willingness to pay
○ Evaluate if we have seen the promise of AI come to fruition in this current period of turbulence. Has it done the job that we thought it would?
○ Develop a methodology of how to split personal and non-personal promotion
TAILORED MEDICAL PHARMA INDUSTRY INITIATIVES
The medical pharma marketing industry, to date, has been an underserved community in networks, events and content. At Momentum Health, we are committed to developing not only virtual events – and live events once it is safe to do so – but creating value in non-traditional content creation, network expansion and professional development on a year round basis.
To that end we are developing a Thought Leadership Council to provide a framework for a year round think tank of industry experts across enterprises of all sizes and scale to influence and advance the medical phama/medtech community. This will build a foundation as a vehicle for ideation that is essentially designed by the industry, for the industry.
To that end we are developing a Thought Leadership Council to provide a framework for a year round think tank of industry experts across enterprises of all sizes and scale to influence and advance the medical phama/medtech community. This will build a foundation as a vehicle for ideation that is essentially designed by the industry, for the industry.
THOUGHT LEADERSHIP COUNCIL FOR MEDICAL PHARMA
The aim is to create a continuum of information sharing within a community of marketing experts. This will drive ongoing industry dialogue at a time where traditional face to face sales calls and meetings with customers are no longer possible with COVID-19. You can share and evaluate concepts and derive knowledge for yourself and your organization. Even when in-person meetings are safe to attend, we want to cultivate a community of industry experts that are dedicated to improving the state of play for pharma.
Unlike traditional advisory boards, the agenda isn’t driven with a particular event in mind. The value for each individual is in having a safe platform to share the challenges you are facing, the best practices that your peers utilized to overcome challenges, pivots made or just validating general trends you are seeing. Having an expert, peer-led sounding board/think tank that takes place quarterly will help to drive meaningful solutions and processes with real outcomes.
WHO SHOULD ATTEND
✔ SVPs
✔ VPs
✔ Directors
✔ Heads
✔ Managers from the pharmaceutical
✔ Biotechnology
✔ Medical Device Industries
✔ Marketing
✔ Digital Marketing
✔ Digital Strategy
✔ Integrated Marketing
✔ Multichannel Marketing
✔ VPs
✔ Directors
✔ Heads
✔ Managers from the pharmaceutical
✔ Biotechnology
✔ Medical Device Industries
✔ Marketing
✔ Digital Marketing
✔ Digital Strategy
✔ Integrated Marketing
✔ Multichannel Marketing
✔ Social Media
✔ Mobile Marketing
✔ eMarketing
✔ eBusiness
✔ Global Marketing
✔ Interactive Services
✔ Commercial Excellence
✔ Commercial Operations/ Capabilities
✔Innovation
✔ Patient Solutions
✔ Customer Interaction/ Engagement
✔ Customer Insights
✔ Mobile Marketing
✔ eMarketing
✔ eBusiness
✔ Global Marketing
✔ Interactive Services
✔ Commercial Excellence
✔ Commercial Operations/ Capabilities
✔Innovation
✔ Patient Solutions
✔ Customer Interaction/ Engagement
✔ Customer Insights
✔ Field Force/SFE
✔ Brand Management
✔ Product Management
✔ Strategic Operations
✔ PR/Communications
✔ New Media
✔ Advertising and Promotions
✔ IT
✔ Clinical Innovation
✔ Medical Affairs
✔ Legal Counsel and MLR
✔ Compliance
✔ Brand Management
✔ Product Management
✔ Strategic Operations
✔ PR/Communications
✔ New Media
✔ Advertising and Promotions
✔ IT
✔ Clinical Innovation
✔ Medical Affairs
✔ Legal Counsel and MLR
✔ Compliance
MEMBERSHIP IS ALMOST AT CAPACITY FOR 2020
Please Fill Out This Form If You Are Interested To Know More About The Thought Leadership Council For The Medical PHARMA /Medtech Community
THANK YOU TO OUR SPONSORS
THANK YOU TO OUR MEDIA PARTNERS
